UBC Professor Mohammad Zarifi and his team at Microelectronics and Gigahertz Applications (OMEGA) Lab have developed a low-cost, contactless, compact, and reusable electromagnetic detector that behaves as a quick as well as dependable antimicrobial resistance assessment method utilizing microwave detecting new tech.
Scientists at UBC have discovered a mechanism for tracking bacteria reactions to an antibiotic in healthcare facilities, paving the way for individuals to get tailored antimicrobial treatment. This technology can be more used in finding the presence of various bacteria on different surfaces and that too within a few seconds.
Personalized Antibiotic Therapy And A New Option
As per experts, this method can be more useful in case of disinfection of OTs and labs as well as other areas where the presence of bacteria can be harmful. The device used for such Tests is compact and hence easy to move from OT to any other area as per the requirements.
The freshly designed sensors intend to address the shortcomings of the current Antibiotic Susceptibility Test (AST) by reducing the time and expense of conducting the testing and also enhancing the mobility of the AST for usage in distant areas. This new method can easily detect and remove bacteria from any surface.
Antimicrobial overuse, as per the World Health Organization, has resulted in an increase in bacterial resistance to medication therapies. As just a consequence, the freshly developed “superbugs” have placed significant pressure on wellbeing institutions around the world, according to Zarifi.
“Many types of bacteria are continuously evolving to develop resistance to antibiotics. This is a pressing issue for hospitals around the globe, while sensor and diagnosis technology has been slow to adapt,” explains Zarifi, who teaches at the School of Engineering.
Current AST methods are costly, and findings might require up to 48 hrs to complete.
“Longer wait times can significantly delay the treatments patients receive, which can lead to further medical complications or even fatalities. This method showcases the requirement for a reliable, rapid, and cost-effective detection tool,”‘ he says.
The UBC group created a novel detector that may detect bacterial development differences when any observable indications appear. As a result, the quantity or kind of antibiotic used to tackle a particular bacteria illness could be perfectly alright.
“Our ultimate goal is to reduce inappropriate usage of antibiotics and enhance the quality of care for the patients,” says Zarifi. “The more quality tools like this that health-care practitioners have at their disposal, the greater their ability to combat bacteria and viruses.”
Presently, the bulk of cell therapy therapeutic applications is centered on cancer therapy and effective diagnosis. Genetic abnormalities should be recognized as soon as feasible as to detect cancers effectively. This necessitates the development of exceedingly precise approaches for early detection. Nanotechnological ideas, such as the ability to access and analyze individual cells, may be able to address this issue. The present state of knowledge in this sector would be a crucial foundation in the establishment of personalized healthcare.
The National Sciences and Engineering Council for Innovation, and CMC Microsystems provided financial and instrumental assistance for this study, which was published in Nature Scientific Announcements.
We offered an outline of certain exciting advancements in nanomedical science and usage in this article. Because the area is rapidly evolving, this study will not be able to cover all elements of modern biomedicine in depth. Our primary goal has been to prove the extremely transdisciplinary nature of the field on the one hand, as well as to provide insight into recent advancements and study topics in science, biology, physics, and engineering that have the potential to revolutionize medical treatments and diagnostic tools on the other.